Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods

Mushtaq, Shazad, Warner, Marina, Johnson, Alan P and Livermore, David M (2004) Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. Journal of Antimicrobial Chemotherapy, 54 (3). pp. 617-20. ISSN 0305-7453

Full text not available from this repository. (Request a copy)

Abstract

Dalbavancin is a long-half-life (9-12 days) glycopeptide, now in Phase 3 development. Its pharmacokinetics may facilitate home intravenous therapy, early discharge and long prophylaxis.

Item Type:	Article
Uncontrolled Keywords:	anti-bacterial agents,culture media,drug resistance, multiple, bacterial,glycopeptides,microbial sensitivity tests,staphylococcus,streptococcus,teicoplanin
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	06 Jan 2014 15:04
Last Modified:	21 Oct 2025 23:42
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46736
DOI:	10.1093/jac/dkh401

Actions (login required)

View Item